the MODY link nurse project - National Genetics Education and ...
the MODY link nurse project - National Genetics Education and ...
the MODY link nurse project - National Genetics Education and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
An educational model for <strong>the</strong><br />
integration of genetics into<br />
diabetes care: <strong>the</strong> <strong>MODY</strong> <strong>link</strong><br />
<strong>nurse</strong> <strong>project</strong><br />
Maggie Shepherd,<br />
Hea<strong>the</strong>r McMahon, Helen John,
Background<br />
• <strong>MODY</strong> (maturity onset diabetes of <strong>the</strong><br />
young) is a genetic form of diabetes<br />
• Accounts for 1% of diabetes (average<br />
diabetic clinic of 5000 would expect to have<br />
50 <strong>MODY</strong> patients)<br />
• <strong>MODY</strong> is often misdiagnosed as type 1<br />
diabetes<br />
• Genetic testing confirming subtype of<br />
<strong>MODY</strong> can alter treatment
<strong>MODY</strong> <strong>link</strong> <strong>nurse</strong>s (MLNs)<br />
• Experienced Diabetes Specialist Nurses<br />
(DSNs) seconded to MLN <strong>project</strong> for 3½<br />
hours a week<br />
• After training: raise awareness of <strong>MODY</strong><br />
<strong>and</strong> o<strong>the</strong>r genetic forms of diabetes<br />
• Support families inc. transferring from insulin<br />
to sulphonylurea tablets<br />
• Receive support from clinical <strong>and</strong> scientific<br />
staff in Exeter by phone/e-mail
Locations of <strong>MODY</strong> <strong>link</strong> <strong>nurse</strong>s<br />
4 intakes of MLNs:<br />
• Phase 1 - July 2002<br />
(initial funding 02-04)<br />
• Phase 2 - May 2003<br />
(extra funding 02-04)<br />
• Phase 3 – March 2004<br />
(extra funding 04-06)<br />
• Phase 4 – Sept 2004<br />
Implications for training<br />
Issues re recruitment
Training<br />
• Training at <strong>the</strong> Royal Devon <strong>and</strong> Exeter Hospital<br />
(initially 3 days) – input from clinicians, scientists,<br />
DSNs <strong>and</strong> clinical genetics teams<br />
• Includes: sub-types of <strong>MODY</strong>, genetic counselling /<br />
implications of genetic testing, identifying <strong>MODY</strong><br />
families, o<strong>the</strong>r genetic types of diabetes<br />
• When new in post each MLN is allocated a mentor<br />
MLN<br />
• On-going training (1½ days) every 4 months when<br />
all <strong>the</strong> MLNs meet
Presentations<br />
• MLNs give presentations about <strong>MODY</strong><br />
to multi-disciplinary diabetes teams in<br />
<strong>the</strong>ir allocated area<br />
• Presentations are based on talks from<br />
Exeter, case studies also used<br />
• Adult <strong>and</strong> paediatric teams <strong>and</strong> renal<br />
<strong>and</strong> obstetric teams included<br />
• Referrals generated from talks
Patient referrals<br />
• MLN takes a detailed history, draws <strong>the</strong> family<br />
tree as well as explaining <strong>and</strong> counselling<br />
families regarding testing <strong>and</strong> possible<br />
implications of results<br />
• Potential families are discussed with <strong>the</strong> Exeter<br />
team by phone or e-mail<br />
• MLN liaises with patients’ local diabetes team /<br />
clinical genetics service as necessary
New opportunities<br />
• The MLNs use <strong>the</strong> network as an informal<br />
support group<br />
• Presentation of a poster at <strong>the</strong> annual<br />
professional conference (Diabetes UK)<br />
• Writing for publication<br />
• Involvement in setting up new <strong>MODY</strong><br />
clinics or joint Diabetes clinics with Clinical<br />
<strong>Genetics</strong> teams
Evaluation: 3 key areas<br />
MLN knowledge<br />
• Underst<strong>and</strong>ing genetic<br />
terms<br />
• Confidence performing<br />
activities<br />
• Case studies<br />
Presentations<br />
• MLN <strong>and</strong> participants<br />
evaluate session<br />
Pre–Ed At 1yr<br />
Evaluation of genetic testing<br />
• Number of patients referred for testing increased<br />
from average of 6.7 per month (pre-MLNs) to 16.4<br />
• Percentage positive genetic tests in index cases<br />
increased from 22% (pre-MLNs) to 25%. Higher<br />
proportion of patients referred from regions with<br />
MLNs have a positive genetic test<br />
Positive tests<br />
35%<br />
30%<br />
25%<br />
20%<br />
15%<br />
10%<br />
22%<br />
27%<br />
23%<br />
31%<br />
16%<br />
MLN region<br />
non-MLN<br />
region<br />
5%<br />
0%<br />
Pre MLN<br />
<strong>project</strong><br />
June 2002-July<br />
2003<br />
July 2003-<br />
Jan2004
What are <strong>the</strong> benefits of using a<br />
diabetes specialist <strong>nurse</strong> network ?<br />
• longst<strong>and</strong>ing clinical experience in diabetes<br />
- good knowledge base of diabetes<br />
management / treatment options<br />
- initiate, supervise & evaluate <strong>the</strong>rapy changes<br />
• part of established clinical networks<br />
across primary & secondary care<br />
- adult / paediatric diabetes, obstetrics & gynae,<br />
renal, etc.
Benefits of using DSN network (cont)<br />
• long continuity of contact with patients<br />
- well placed to identify possible <strong>MODY</strong> / atypical<br />
diabetes<br />
- appreciation of pt experience<br />
• hold key skills<br />
- patient education / support<br />
presentation, communication, counselling<br />
• used to working autonomously & as part of a<br />
multi professional team
Benefits to <strong>the</strong> DSN<br />
• Unique professional development opportunity<br />
- exciting, prestigious role<br />
- able to join <strong>the</strong> <strong>project</strong> on secondment<br />
- develop knowledge & acquire new skills<br />
- act as a resource to colleagues<br />
- enjoyable & rewarding !<br />
• able to enhance / change clinical practice<br />
• close <strong>link</strong>s with Exeter team & <strong>MODY</strong> <strong>link</strong> <strong>nurse</strong><br />
network<br />
• wider clinical networks
Conclusion<br />
• MLNs have increased own knowledge of<br />
genetics <strong>and</strong> disseminated this to diabetes<br />
teams in <strong>the</strong>ir regions<br />
• The pick-up rate for genetic testing has<br />
increased since <strong>the</strong> inception of <strong>the</strong> <strong>project</strong><br />
• The success of training DSNs in genetics<br />
could provide a model for disseminating<br />
genetic information in o<strong>the</strong>r conditions